<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-45021</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Fosun Pharma GHP</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Shanghai Fosun Pharmaceutical (Group) Co. Ltd., (Fosun Pharma, or the Company) is a leading manufacturer of pharmaceutical products and medical devices in China. The Companys business spans across the healthcare value chain from research &amp; development, pharmaceutical manufacturing, medical devices and diagnosis, to healthcare services, pharmaceutical distribution and retail. Fosun Pharma has been listed on the Shanghai Stock Exchange since 1998 and Hong Kong Stock Exchange since 2012.   &#xA0;  The proposed IFC investment will primarily support Fosun Pharmas manufacturing and distribution of COVID-19 related medical products, including the COVID-19 vaccine co-developed by Pfizer / BioNTech and COVID-19 testing kits and in China (the Project).</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">The most significant expected Project-level effect is the broadened access to COVID-19 vaccine. Beyond the project, it is anticipated that the investment will enhance the resilience of healthcare supply chains in emerging markets.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-45021" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-05-25" type="1"></activity-date>
  <activity-date iso-date="2021-06-29" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">0  0  0  0  0  0  0  0  0.0000         Environmental documents will be made accessible to locally affected communities.</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Shanghai Fosun Pharmaceutical (Group) Co., Ltd.  Mr. Zhang Xiang  Finance Manager  +86-21-33987000  zhangxiang1@fosunpharma.com  Building A, No. 1289 Yishan Road, Shanghai, China  https://www.fosunpharma.com/en/</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CN" percentage="100">
   <narrative xml:lang="EN">China</narrative>
  </recipient-country>
  <location ref="CN-China">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Fosun Pharma is headquartered in Shanghai, China. The Project involves capital expenditures associated with expansion of cold-chain warehousing and distribution networks across China.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>35.0000000000 105.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">other</narrative>
  </sector>
  <tag code="COVID-19" vocabulary="99"></tag>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $200.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2021-05-25"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-05-25">200000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">200000000</value>
   <receiver-org>
    <narrative xml:lang="EN">SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetailSII/45021">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/#/projectDetailSII/45021">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
